FY26 H1 Results
Dr. Martens plc has released its FY26 H1 results on 20th November. Please watch the event using the link below.
Why invest
We have a number of competitive strengths which act as differentiators and position the business for growth.
>65
years of heritage
65%
Revenue from DTC
£787.6m
Revenue
£34.1m
Adjusted PBT
10.5
million pairs sold
60+
countries operated in
£37.0m
EBIT
4.7%
EBIT margin
Source: DM Audited Accounts, Company data.
Note: March financial year end. All figures are FY25, unless otherwise specified.